Unhealthy behaviours for self-management of HIV-related peripheral neuropathy

Abstract

The prevalence of peripheral neuropathy is frequent in HIV disease and is often associated with antiretroviral therapy. Unhealthy behaviours, particularly substance-use behaviours, are utilized by many HIV-positive individuals to manage neuropathic symptoms. As part of a larger study on self-care for symptoms in HIV disease, this study analyzed the prevalence and characteristics of unhealthy behaviours to self-manage peripheral neuropathy in HIV disease. Sociodemographic and disease-related correlates and unhealthy behaviours were examined in a convenience sample of 1,217 respondents who were recruited from data collection sites in several US cities, Puerto Rico, Colombia, and Taiwan. Results of the study indicated that respondents with peripheral neuropathy (n=450) identified a variety of unhealthy self-care behaviours including injection drug use, oral drug use, smoking cigarettes and alcohol ingestion. Specific unhealthy behaviours that participants reported to alleviate peripheral neuropathy included use of marijuana (n=67), smoking cigarettes (n=139), drinking alcohol (n=81) and street drugs (n=30). A subset of those individuals (n=160), who identified high levels of neuropathy (greater than five on a scale of 1-10), indicated significantly higher use of amphetamines and injection drug use in addition to alcohol use and cigarette smoking. For participants from Norway, substance use (using alcohol: 56%) was one of the most frequent self-management strategies. Implications for clinical practice include assessment and education of persons with HIV for self-care management of the complex symptom of peripheral neuropathy.

A qualitative exploration of chronic pain and opioid treatment among HIV patients with drug use disorders

“…Given participants’ dissatisfaction and challenges with commonly used analgesics, future research and clinical practice should consider non-pharmacological biopsychosocial therapies (36–40) that are socioculturally tailored, the creation of harm reduction-oriented clinic environments where patients can openly discuss their drug use disorders to ensure appropriate pain management regimens (harm reduction refers to strategies and approaches that aim to reduce the negative consequences of drug abuse, rather than focusing on eliminating the use of licit or illicit drugs (41)), and empowering patients with pain-self management strategies to improve patients’ quality of life (21, 42, 43). …”

Tobacco use among people living with HIV: analysis of data from Demographic and Health Surveys from 28 low-income and middle-income countries

“…However, most HIV care providers are less likely to correctly identify current smokers and feel confident in their ability to influence smoking cessation than are general health workers 46 . Given the overwhelming task of managing HIV infection and its complications, tobacco cessation might also be less of a priority from both providers' and patients' perspectives 25, 42, 47. Future research action to improve the health of this population could therefore include exploring effective and cost-effective tobacco cessation interventions for people living with HIV that are sustainable and scalable in low-resource settings.…”

The Impact of Marijuana Use on the Successful Aging of HIV-Infected Adults

“…Of the seven randomized controlled trials included in the review, data for improvement in morbidity and mortality were limited by small study size and short study duration 9 . Marijuana use among persons with HIV infection has primarily been described in the context of palliative therapy, in addition to studies exploring risk behavior, non-adherence with ART, and association of marijuana use with other substances 10–12 . Indeed, marijuana has been reported to alleviate commonly-reported symptoms often seen in the course of HIV infection including improvements in appetite, weight loss, nausea, constipation, pain, neuropathy, tremors, anxiety, depression, and fatigue 8 .…”